Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-19 · accession 0001415889-25-022540 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-20 | 2025-08-19 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale+OE | $16.61 | -16.2K | 34.1K | -32% | -$268.4K |
| D | 2025-08-20 | 2025-08-19 | BBNX | Hopman Mark | Chief Commercial Off | M - OptEx | $5.10 | +16.2K | 50.3K | +47% | +$82.4K |
| D | 2025-08-20 | 2025-08-19 | BBNX | Hopman Mark | Chief Commercial Off | M - OptEx | $0.00 | -16.2K | 67.1K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | S | D | 16,158 | $16.61 | 34,132 | D | — | — | (F2) The weighted average sale price for the transaction reported was $16.6095 and the range of prices were between $16.26 and $17.1719. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-08-19 | M | A | 16,158 | $5.10 | 50,290 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-08-19 | M | D | 16,158 | $0.00 | 67,084 | D | $5.10 · — to 2033-07-26 | 16,158 Common Stock | (F3) One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. |